CoChat

A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials

Open access
Zhong, Zhuoyuan, Wang, Limin, Wen, Xiaojun, Liu, Yunyun, Fan, Yafei, Liu, Zhonglin · 2017 · Neuropsychiatric Disease and Treatment

The DOI matches its Crossref record; 61 of the 63 references it cites were found in a registry or an index.

Abstract

Background: Selective serotonin reuptake inhibitors (SSRIs) and serotonin and noradrenaline reuptake inhibitors (SNRIs) have been commonly prescribed for depression treatment. However, their effects on blood pressure are unclear. Materials and methods: Effects on blood pressure of depressive patients in two groups (SSRIs versus placebo and SSRIs versus SNRIs) were evaluated. A search was conducted for double-blind, randomized controlled trials (RCTs) in PubMed, EMBASE, ISI Web of Science, PsycNET, CCRCT, and DARE (up to March 2017). The outcomes were systolic blood pressure (SBP) changes and diastolic blood pressure (DBP) changes from baseline to endpoint or to a certain period of treatment duration. Weighted mean differences (WMDs) and 95% CIs were calculated and pooled using random effects models. The χ 2 test and I 2 statistics were used to assess heterogeneity. Funnel plots, Begg’s test, and Egger’s test were used to estimate publication bias. Results: A total of 23 RCTs involving 13,285 participants were included. Patients on SSRIs showed no significant differences in blood pressure changes compared with placebo. In the group of SSRIs versus SNRIs, overall SBP changes and DBP changes revealed statistical significances (WMD 1.5 mmHg, 95% CI -2.15, -0.84, Z =4.46, P <0.00001 and WMD 1.34 mmHg, 95% CI -1.92, -0.75, Z =6.18, P <0.00001). Subgroup analyses on treatment duration and age further evidenced these findings. Conclusion: It was established that SSRIs did not affect blood pressure, while SNRIs led to a modest increase in SBP and DBP with statistical significance compared with SSRIs. Keywords: meta-analysis, blood pressure change, depression treatment, selective serotonin reuptake inhibitors, serotonin and noradrenaline reuptake inhibitors, depression, antidepressant, systolic blood pressure, diastolic blood pressure

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/ndt.s141832

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flow chart of study selection. Abbreviation: RCT, randomized controlled trial.
Figure 1 Flow chart of study selection. Abbreviation: RCT, randomized controlled trial.CC BY-NC · PubMed Central
Figure 2 Assessment of risk of bias for each individual trial. ?, unclear risk of bias; +, low risk of bias.
Figure 2 Assessment of risk of bias for each individual trial. ?, unclear risk of bias; +, low risk of bias.CC BY-NC · PubMed Central
Figure 3 A forest plot of RCTs comparing SSRI group with placebo group for change in systolic blood pressure. Abbreviations: RCTs, randomized controlled trials; SSRI, selective serotonin reuptake inhibitor.
Figure 3 A forest plot of RCTs comparing SSRI group with placebo group for change in systolic blood pressure. Abbreviations: RCTs, randomized controlled trials; SSRI, selective serotonin reuptake inhibitor.CC BY-NC · PubMed Central
Figure 4 A forest plot of RCTs comparing SSRI group with placebo group for change in diastolic blood pressure. Abbreviations: RCTs, randomized controlled trials; SSRI, selective serotonin reuptake inhibitor.
Figure 4 A forest plot of RCTs comparing SSRI group with placebo group for change in diastolic blood pressure. Abbreviations: RCTs, randomized controlled trials; SSRI, selective serotonin reuptake inhibitor.CC BY-NC · PubMed Central
Figure 5 A forest plot of RCTs comparing SSRI group with SNRI group for change in systolic blood pressure change of short-/long-term duration. Abbreviations: RCTs, randomized controlled trials; SSRI, selective serotonin reuptake inhibitor; SNRI, serotonin and noradrenaline reuptake inhibitor.
Figure 5 A forest plot of RCTs comparing SSRI group with SNRI group for change in systolic blood pressure change of short-/long-term duration. Abbreviations: RCTs, randomized controlled trials; SSRI, selective serotonin reuptake inhibitor; SNRI, serotonin and noradrenaline reuptake inhibitor.CC BY-NC · PubMed Central
Figure 6 A forest plot of RCTs comparing SSRI group with SNRI group for change in diastolic blood pressure change of short-/long-term duration. Abbreviations: RCTs, randomized controlled trials; SSRI, selective serotonin reuptake inhibitor; SNRI, serotonin and noradrenaline reuptake inhibitor.
Figure 6 A forest plot of RCTs comparing SSRI group with SNRI group for change in diastolic blood pressure change of short-/long-term duration. Abbreviations: RCTs, randomized controlled trials; SSRI, selective serotonin reuptake inhibitor; SNRI, serotonin and noradrenaline reuptake inhibitor.CC BY-NC · PubMed Central
Figure 7 A forest plot of RCTs comparing SSRI group with SNRI group for change in systolic blood pressure change of different ages. Abbreviations: RCTs, randomized controlled trials; SSRI, selective serotonin reuptake inhibitor; SNRI, serotonin and noradrenaline reuptake inhibitor.
Figure 7 A forest plot of RCTs comparing SSRI group with SNRI group for change in systolic blood pressure change of different ages. Abbreviations: RCTs, randomized controlled trials; SSRI, selective serotonin reuptake inhibitor; SNRI, serotonin and noradrenaline reuptake inhibitor.CC BY-NC · PubMed Central
Figure 8 A forest plot of RCTs comparing SSRI group with SNRI group for change in diastolic blood pressure change of different ages. Abbreviations: RCTs, randomized controlled trials; SSRI, selective serotonin reuptake inhibitor; SNRI, serotonin and noradrenaline reuptake inhibitor.
Figure 8 A forest plot of RCTs comparing SSRI group with SNRI group for change in diastolic blood pressure change of different ages. Abbreviations: RCTs, randomized controlled trials; SSRI, selective serotonin reuptake inhibitor; SNRI, serotonin and noradrenaline reuptake inhibitor.CC BY-NC · PubMed Central
Figure 9 Begg’s test and Egger’s test identified no publication bias. In the group of SSRI versus placebo: Begg’s test: Z=0.33, P=0.742 (A); Egger’s test: t=0.36, P=0.724 (B). In the group of SSRI versus SNRI: Begg’s test: Z=1.19, P=0.236 (C); Egger’s test: t=0.85, P=0.405 (D). Abbreviations: WMD, weighted mean difference; SSRI, selective serotonin reuptake inhibitor; SNRI, serotonin and noradrenaline reuptake inhibitor.
Figure 9 Begg’s test and Egger’s test identified no publication bias. In the group of SSRI versus placebo: Begg’s test: Z=0.33, P=0.742 (A); Egger’s test: t=0.36, P=0.724 (B). In the group of SSRI versus SNRI: Begg’s test: Z=1.19, P=0.236 (C); Egger’s test: t=0.85, P=0.405 (D). Abbreviations: WMD, weighted mean difference; SSRI, selective serotonin reuptake inhibitor; SNRI, serotonin and noradrenaline reuptake inhibitor.CC BY-NC · PubMed Central
Figure 10 The sensitivity analysis showed the influence of omitting each study in turn in the meta-analysis of SSRI versus placebo. The pooled WMDs (95% CI) ranged from −0.19 (−0.89, 0.50) to 0.10 (−0.55, 0.76) in systolic blood pressure change (A), and from −0.01 (−0.53, 0.52) to 0.19 (−0.34, 0.72) in diastolic blood pressure change (B), with all showing no statistical significance. Notes: (A) The sensitivity analysis showed the influence of omitting each study in turn in the meta-analysis of selective serotonin reuptake inhibitor versus placebo in systolic blood pressure change. (B) The sensitivity analysis showed the influence of omitting each study in turn in the meta-analysis of selective serotonin reuptake inhibitor versus placebo in diastolic blood pressure change. Abbreviations: SSRI, selective serotonin reuptake inhibitor; WMDs, weighted mean differences.
Figure 10 The sensitivity analysis showed the influence of omitting each study in turn in the meta-analysis of SSRI versus placebo. The pooled WMDs (95% CI) ranged from −0.19 (−0.89, 0.50) to 0.10 (−0.55, 0.76) in systolic blood pressure change (A), and from −0.01 (−0.53, 0.52) to 0.19 (−0.34, 0.72) in diastolic blood pressure change (B), with all showing no statistical significance. Notes: (A) The sensitivity analysis showed the influence of omitting each study in turn in the meta-analysis of selective serotonin reuptake inhibitor versus placebo in systolic blood pressure change. (B) The sensitivity analysis showed the influence of omitting each study in turn in the meta-analysis of selective serotonin reuptake inhibitor versus placebo in diastolic blood pressure change. Abbreviations: SSRI, selective serotonin reuptake inhibitor; WMDs, weighted mean differences.CC BY-NC · PubMed Central
Figure 11 The sensitivity analysis showed the influence of omitting each study in turn in the meta-analysis of SSRI versus SNRI. The pooled WMDs (95% CI) ranged from −1.58 (−2.22, −0.93) to −1.36 (−1.94, −0.77) in systolic blood pressure change (A), and from −1.43 (−2.01, −0.85) to −1.22 (−1.77, −0.67) in diastolic blood pressure change (B), with all showing statistical significances. Notes: (A) The sensitivity analysis showed the influence of omitting each study in turn in the meta-analysis of selective serotonin reuptake inhibitor versus serotonin and noradrenaline reuptake inhibitor on systolic blood pressure change. (B) The sensitivity analysis showed the influence of omitting each study in turn in the meta-analysis of selective serotonin reuptake inhibitor versus serotonin and noradrenaline reuptake inhibitor on diastolic blood pressure change. Abbreviations: SNRI, serotonin and noradrenaline reuptake inhibitor; WMDs, weighted mean differences.
Figure 11 The sensitivity analysis showed the influence of omitting each study in turn in the meta-analysis of SSRI versus SNRI. The pooled WMDs (95% CI) ranged from −1.58 (−2.22, −0.93) to −1.36 (−1.94, −0.77) in systolic blood pressure change (A), and from −1.43 (−2.01, −0.85) to −1.22 (−1.77, −0.67) in diastolic blood pressure change (B), with all showing statistical significances. Notes: (A) The sensitivity analysis showed the influence of omitting each study in turn in the meta-analysis of selective serotonin reuptake inhibitor versus serotonin and noradrenaline reuptake inhibitor on systolic blood pressure change. (B) The sensitivity analysis showed the influence of omitting each study in turn in the meta-analysis of selective serotonin reuptake inhibitor versus serotonin and noradrenaline reuptake inhibitor on diastolic blood pressure change. Abbreviations: SNRI, serotonin and noradrenaline reuptake inhibitor; WMDs, weighted mean differences.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 48

Metadata

Authors
Zhong, Z., Wang, L., Wen, X., Liu, Y., Fan, Y., & Liu, Z.
Affiliations
  • The People's Hospital of Guangxi Zhuang Autonomous Region (CN)
  • Guangdong General Hospital (CN)
  • Guangzhou First People's Hospital (CN)
  • Sun Yat-sen University (CN)
Corresponding author
Liu, Zhonglin
Venue
Neuropsychiatric Disease and Treatment
Published
2017-11
Volume
Volume 13
Pages
2781-2796
ISSN
  • 1176-6328 (ISSN-L)
  • 1178-2021
OpenAlex
W2767504574
Cited by
46
References
63
Citations by year
2026: 2 · 2025: 4 · 2024: 8 · 2023: 4 · 2022: 8 · 2021: 6 · 2020: 7 · 2019: 4 · 2018: 3
FWCI
0.49
Type
journal article
Language
en
Open access
Locations
  • Neuropsychiatric Disease and Treatment (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Funders
Science and Technology Planning Project of Guangdong Province (KLB09001, 2014A020212148)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Keywords
selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, blood pressure, depression treatment, antidepressants, systolic blood pressure, diastolic blood pressure

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.